| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2023 | CODX Co-Diagnostics, Inc. | Brown Brian Lee | Chief Financial Officer | Buy | 3,000 | $1.90 | $5,697.00 | +4.1% | -43.2% | -42.1% | |
| Mar 20, 2023 | ENOV Enovis Corp | Berry Phillip Benjamin (ben)51 | SVP, Chief Financial Officer | Sell | 600 | $51.84 | $31,104.00 | -2.8% | +16.6% | +15.7% | |
| Mar 20, 2023 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 4,130 | $20.82 | $85,986.60 | -3.2% | +0.4% | -89.6% | |
| Mar 20, 2023 | CTKB Cytek Biosciences, Inc. | Yan Ming77 | Chief Technology Officer | Sell | 20,000 | $9.29 | $185,800.00 | -0.3% | -8.9% | -26.8% | |
| Mar 20, 2023 | XAIR Beyond Air, Inc. | Bentsur Ron64 | Director | Buy | 2,300 | $6.48 | $14,904.00 | +1.6% | -3.7% | -76.2% | |
| Mar 17, 2023 | ZBH Zimmer Biomet Holdings, Inc. | Phipps Chad F53 | Sr. Vp/ Gen Counsel/ Secretary | Sell | 23,045 | $124.50 | $2,869,112.56 | -20.3% | +14.7% | +0.7% | |
| Mar 17, 2023 | VMD Viemed Healthcare, Inc. | Kaushal Nitin82 | Director | Sell | 12,087 | $13.43 | $162,328.41 | -10.5% | -0.2% | -2.4% | |
| Mar 17, 2023 | XAIR Beyond Air, Inc. | Forbes William P49 | Director | Buy | 5,000 | $6.46 | $32,300.00 | +103.0% | -7.4% | -76.2% | |
| Mar 17, 2023 | XAIR Beyond Air, Inc. | Lisi Steven A.50 | CEO And Chairman Of The Board | Buy | 10,000 | $6.46 | $64,600.00 | +0.7% | -7.4% | -76.2% | |
| Mar 17, 2023 | INFU Infusystem Holdings, Inc | Lachance Carrie54 | President And COO | Buy | 3,000 | $6.82 | $20,449.50 | +2.4% | +32.5% | +34.5% | |
| Mar 17, 2023 | INFU Infusystem Holdings, Inc | Steele Barry G | Executive VP And CFO | Buy | 3,000 | $6.96 | $20,866.50 | +5.6% | +32.5% | +34.5% | |
| Mar 17, 2023 | STAA Staar Surgical Co | Holliday Keith71 | Chief Technology Officer | Sell | 823 | $61.97 | $51,001.31 | -2.9% | -12.2% | -37.1% | |
| Mar 17, 2023 | ECOR Electrocore, Inc. | Goldberger Daniel S69 | Chief Executive Officer | Buy | 1,000 | $3.45 | $3,445.00 | +1.5% | +35.8% | +101.8% | |
| Mar 17, 2023 | STIM Neuronetics, Inc. | Cannell Capital LLC69 | 10% Owner | Buy | 59,716 | $2.90 | $173,099.96 | +1.0% | -17.3% | +37.8% | |
| Mar 16, 2023 | MMSI Merit Medical Systems Inc | Peterson Neil51 | Chief Operating Officer | Sell | 8,000 | $68.75 | $550,000.00 | -100% | +16.9% | +1.3% | |
| Mar 16, 2023 | XAIR Beyond Air, Inc. | Lucera Erick | Director | Buy | 2,000 | $6.82 | $13,634.00 | +85.4% | -15.5% | -77.3% | |
| Mar 16, 2023 | PRCT Procept Biorobotics Corp | Nouri Alaleh50 | EVP, CLO, Corp. Sec. | Sell | 304 | $31.84 | $9,679.36 | -0.9% | +8.1% | +48.2% | |
| Mar 16, 2023 | PRCT Procept Biorobotics Corp | Shiblaq Hisham55 | EVP, Chief Comm. Officer | Sell | 246 | $31.84 | $7,832.64 | -0.5% | +8.1% | +48.2% | |
| Mar 16, 2023 | ENOV Enovis Corp | Perfall A Clayton | Director | Sell | 2,793 | $52.13 | $145,585.13 | -8.0% | +11.2% | +11.6% | |
| Mar 16, 2023 | PRCT Procept Biorobotics Corp | Zadno Reza73 | President, CEO | Sell | 5,335 | $31.84 | $169,866.40 | -3.3% | +8.1% | +48.2% | |
| Mar 16, 2023 | PRCT Procept Biorobotics Corp | Waters Kevin | EVP, CFO | Sell | 706 | $31.84 | $22,479.04 | -1.2% | +8.1% | +48.2% | |
| Mar 16, 2023 | DXCM Dexcom Inc | Dolan Matthew Vincent63 | SVP Corporate Strategy-develop | Sell | 2,303 | $115.00 | $264,845.00 | -6.4% | +10.9% | +13.9% | |
| Mar 15, 2023 | TMCI Treace Medical Concepts, Inc. | Owens Daniel E.52 | Chief Human Resources Officer | Sell | 6,250 | $22.87 | $142,955.63 | -16.8% | +8.7% | -47.9% | |
| Mar 15, 2023 | RMD Resmed Inc | Farrell Michael J.63 | Chief Executive Officer | Sell | 5,675 | $206.95 | $1,174,450.90 | -1.3% | +3.3% | -7.8% | |
| Mar 15, 2023 | LFWD Lifeward Ltd. | Jasinski Lawrence J62 | Chief Executive Officer | Buy | 15,000 | $0.72 | $10,810.50 | New | -17.4% | -17.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.